REGULATED INFORMATION
INSIDE INFORMATION
Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio in Complete Concentric Collapse Patients
Read more »
REGULATED INFORMATION
INSIDE INFORMATION
Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio in Complete Concentric Collapse Patients
Read more »
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert (Belgium), June 30, 2022, 10:30 pm [...] Read more »
Nyxoah Joins the Euronext Tech Leaders Initiative, Included in the Euronext Tech Leaders Index
Mont–Saint–Guibert, Belgium "" June 7, 2022 4:30pm ET / 10:30pm [...] Read more »
FDA Approves Genio 2.1 For Use in DREAM U.S. IDE Pivotal Study
New smartphone application, upgraded activation chip, improved user interface, and stimulation amplitude [...] Read more »
REGULATED INFORMATION
Nyxoah Reports First Quarter 2022 Financial and Operating Results
Mont–Saint–Guibert, Belgium "" May 10, [...] Read more »
REGULATED INFORMATION
Nyxoah Reports First Quarter 2022 Financial and Operating Results
Mont–Saint–Guibert, Belgium [...] Read more »
REGULATED INFORMATION
May 6, 2022, 7:00am CET / 1:00am ET
NYXOAH SA
(Euronext Brussels: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »
Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors
Mont–Saint–Guibert, Belgium "" May 6, 2022, [...] Read more »
Nyxoah to Release First Quarter 2022 Financial Results on May 9 and Host Conference Call on May 10, 2022
Mont–Saint–Guibert, Belgium "" April 28, 2022, 10:30pm CET / [...] Read more »
REGULATED INFORMATION
Nyxoah Reports Full Year 2021 Operating and Financial Results
Mont–Saint–Guibert, Belgium [...] Read more »